Secreted Frizzled Related Protein, sFRP, Fragments and Methods of Use Thereof (as filed) Read more about Secreted Frizzled Related Protein, sFRP, Fragments and Methods of Use Thereof (as filed) US Patent 7,947,651Filed on 2007-05-15
Analogs of Thalidomide as Potential Angiogenesis Inhibitors Read more about Analogs of Thalidomide as Potential Angiogenesis Inhibitors US Patent 8,716,315Filed on 2007-07-19
Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence Read more about Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence US Patent 8,217,222Filed on 2006-09-29
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Sweden04011673.3Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Portugal04011673.3Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Italy04011673.3Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Ireland04011673.3Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Greece04011673.3Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Finland04011673.3Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) Spain04011673.3Filed on 1998-09-22